|
Originally published In Press as doi:10.1074/jbc.M206294200 on July 26, 2002
J. Biol. Chem., Vol. 277, Issue 40, 37551-37558, October 4, 2002
Activation of the Na-K-Cl Cotransporter NKCC1
Detected with a Phospho-specific Antibody*
Andreas W.
Flemmer ,
Ignacio
Giménez,
Brian F. X.
Dowd,
Rachel B.
Darman§, and
Biff
Forbush¶
From the Department of Cellular and Molecular Physiology, Yale
University School of Medicine, New Haven, Connecticut 06520 and the
Mount Desert Island Biological Laboratory,
Salsbury Cove, Maine 04672
Received for publication, June 24, 2002, and in revised form, July 16, 2002
 |
ABSTRACT |
The Na-K-Cl cotransporter NKCC1 is activated by
phosphorylation of a regulatory domain in its N terminus. In the
accompanying paper (Darman, R. B., and Forbush, B. (2002)
J. Biol. Chem. 277, 37542-37550), we identify three
phosphothreonines important in this process. Using a phospho-specific
antibody (anti-phospho-NKCC1 antibody R5) raised against a
diphosphopeptide containing Thr212 and Thr217
of human NKCC, we were readily able to monitor the cotransporter activation state. In 32P phosphorylation experiments with
rectal gland tubules, we show that the R5 antibody signal is
proportional to the amount of 32P incorporated into NKCC1;
and in experiments with NKCC1-transfected HEK-293 cells, we demonstrate
that R5-detected phosphorylation directly mirrors functional
activation. Immunofluorescence analysis of shark rectal gland shows
activation-dependent R5 antibody staining along the
basolateral membrane. In perfused rat parotid glands, isoproterenol
induced staining of both acinar and ductal cells along the basolateral
membrane. Isoproterenol also induced basolateral staining of the
epithelial cells in rat trachea, whereas basal cells in the
subepithelial tissue displayed heavy, non-polarized staining of the
cell membrane. In rat colon, agonist stimulation induced staining along
the basolateral membrane of crypt cells. These data provide direct
evidence of NKCC1 regulation in these tissues, and they further link
phosphorylation of NKCC1 with its activation in transfected cells and
native tissue. The high conservation of the regulatory threonine
residues among NKCC1, NKCC2, and NCC family members, together with the
fact that tissues from divergent vertebrate species exhibit similar
R5-binding profiles, lends further support to the role of this
regulatory locus in vivo.
 |
INTRODUCTION |
NKCC1, the secretory or housekeeping isoform of the Na-K-Cl
cotransporter, is expressed in most cell types, aiding in the regulation of cell volume. In polarized cells of secretory epithelia, NKCC1 is heavily expressed along the basolateral membrane, activated in
response to secretagogues, and paramount for the transepithelial secretion of Cl and water (2). NKCC1-mediated
Cl secretion has been well documented in rat parotid
gland (3, 4), shark rectal gland (5), rat colon (6), and dog
trachea (7). At least in shark rectal gland, the evidence is consistent with an indirect activation of NKCC1 upon agonist stimulation: secretagogues cause a drop in intracellular [Cl ] and
volume via protein kinase A-mediated phosphorylation of apical
chloride channels; in turn, low intracellular [Cl ] and
low cell volume provide activation stimuli for the currently unidentified NKCC1 kinase(s) (2, 8).
Our laboratory (9) and others (10) have linked the phosphorylation of
the intracellular N-terminal domain with NKCC1 activation. In the
accompanying paper, Darman and Forbush (1) describe the phosphorylation
of three residues in this regulatory domain, of which
Thr184 and Thr189 are necessary for maximal
sNKCC11 activation.
Thr189 in particular is demonstrated as being essential for
sNKCC1 up-regulation. The three phosphoacceptor sites reside in a
30-amino acid region of the N terminus that exhibits 80% homology
between sodium-coupled cation chloride cotransporter isoforms and 97%
homology within NKCC1 proteins in species ranging from shark to
human (shark Thr184/Thr189 correspond to human
Thr212/Thr217). This region of the N terminus
also contains a protein phosphatase-1-binding site (RVXF),
which is conserved across divergent species and thought to mediate
regulated dephosphorylation (11).
To date, most studies of NKCC regulation have been conducted in
isolated tissue preparations, cell cultures, or cell-free systems
utilizing [3H]benzmetanide binding,
32P incorporation, or isotopic uptake. Although these
studies have provided a wealth of information at the cellular and
molecular levels, little is known about the phosphorylation state of
NKCC in native tissue. To address this issue, we have developed a
phospho-specific polyclonal antibody (anti-phospho-NKCC1
antibody R5) raised against the in vitro phosphorylated
peptide corresponding to the regulatory domain.
In this report, we demonstrate R5 specificity and sensitivity in
recognizing the phosphorylated conserved threonines. We determine a
positive correlation between NKCC1 activation and
Thr184/Thr189 phosphorylation in
sNKCC1-transfected HEK-293 cells using the R5 antibody. We also
investigate in vivo NKCC1 activity and address the
universality of this regulatory domain by examining R5
immunohistographs of shark rectal gland and several rat secretory
tissues. These data provide a critical link between molecular
regulation studies and the activation profile of NKCC1 in
vivo.
 |
EXPERIMENTAL PROCEDURES |
Antibodies--
A 16-amino acid peptide,
Tyrh208-Argh223-Lys
(YYLRT*FGHNT*MDAVPRK) with an
additional C-terminal lysine residue for coupling, was synthesized by
the Keck Peptide Synthesis Facility at Yale University; the regulatory
phosphothreonines Thr212 and Thr217 (in human
NKCC1) were incorporated directly during synthesis. A rabbit antibody
(anti-phospho-NKCC1 antibody R5; Pocono Rabbit Farms, Canadensis, PA)
was raised against this peptide coupled to maleimidobenzoic
acid-N-hydroxysuccinimide-activated keyhole limpet
hemocyanin (Sigma) using standard procedures. The anti-phospho-NKCC1 antibody will be referred to as R5 for the remainder of the paper. For
immunofluorescence studies, R5 was subjected to positive and negative
affinity purification using the phosphorylated and non-phosphorylated kindred peptides coupled to
N-hydroxysuccinimide-activated Sepharose beads
(Amersham Biosciences) following the manufacturer's instructions.
The specificity of R5 antisera for the immunizing peptide was measured
using an ELISA format. As illustrated in Fig.
1 (upper panel), R5 serum
displayed >20-fold selectivity for the diphosphopeptide compared with
the non-phosphorylated peptide. This high degree of selectivity enables
a sensitive analysis of the phosphorylation state of the conserved
threonines in situ and also Western blot analysis; for most
purposes, the antibody can be effectively employed as diluted serum.
Positive and negative affinity purification of the antibody further
increased the phospho-specificity to >100-fold (Fig. 1, lower
panel); the purified antibody was used for immunofluorescence analyses.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 1.
ELISA analysis of R5 antibodies.
Phosphorylated ( ) and non-phosphorylated ( )
Tyrh208-Argh223-Lys peptides, the
modified phosphorylated Tyr208-Arg223-Lys
peptide ( ), and the water control ( ) were covalently coupled to
N-oxysuccinimide plates and probed with various dilutions of
R5 serum and affinity-purified R5 antibody as shown. Values represent
means and range of duplicate determinations of the optical
density of the ELISA reaction product.
|
|
Unnoticed until after the initial batch of R5 antibody had been
produced, the second aspartate in this peptide was found to have been
modified to an aspartimide during synthetic procedures; the unmodified
peptide was subsequently synthesized for analytic and purification
procedures. Fig. 1 shows that the R5 antibody had a slightly higher
affinity for the modified peptide compared with the unmodified peptide.
We speculate that the modification may have increased the
immunogenicity of the
Tyrh208-Argh223-Lys peptide. In any
case, this antigen was quite successful; the second of two rabbits (R4,
not discussed further here) also produced a high titer
phospho-specific serum, with greater phospho-specificity, but less NKCC
specificity, compared with R5.
Several other antibodies were used to detect NKCC1 independent of its
phosphorylation state. The T4 monoclonal antibody (12) and the N1c
polyclonal antibody (gift of Chris Lytle, University of California,
Riverside, CA) (13) both recognize the C terminus of human NKCC1 in a
wide range of species. J3, J4, and J7 are anti-NKCC1 monoclonal
antibodies that are highly specific for the shark cotransporter (14);
these were used to detect sNKCC1 in ex vivo perfused fixed
gland sections, isolated shark rectal gland tubules, and
sNKCC1-transfected HEK-293 cells.
ELISA and Western Blotting--
For determination of antibody
affinity and phospho-specificity by ELISA, phosphorylated and
non-phosphorylated peptides were covalently coupled to
N-oxysuccinimide binding plates (DNA-Bind, Costar Corp.).
Plates were blocked with 20 mM ethanolamine, pH 8.2; washed
twice with wash buffer (PBS, 1% bovine serum albumin, and 0.1% Triton
X-100); and blocked with 7% milk in PBS in 0.1% Triton X-100. After
washing once with wash buffer and sequential incubations with serially
diluted sera and horseradish peroxidase-conjugated anti-rabbit IgG
antibody, the optical density was measured with a spectrophotometer
using o-phenylenediamine as a substrate.
For Western blotting, samples were subjected to Tricine/SDS gel
electrophoresis (7.5 or 10%) and transferred to polyvinylidene difluoride membranes (Immobilon, Millipore Corp., Bedford, MA). Blots
were sequentially probed with primary and horseradish
peroxidase-conjugated secondary antibodies. Chemiluminescent substrate
was detected using a cooled CCD camera.
NKCC1 in HEK-293 Cells--
Lines of stably transfected HEK-293
cells were handled as described in the accompanying paper (1).
Following appropriate preincubations, cells were solubilized by one of
two procedures. (a) Cells were lysed either in 20 mM HEPES, pH 7.2 (see Fig. 2), or in phosphatase inhibitory
buffer (300 mM NaCl, 60 mM NaF, 10 mM EDTA, 30 mM Na2HPO4,
30 mM sodium pyrophosphate, 40 mM HEPES, 0.2 mM NaVO4, and 0.5 µM calyculin A)
(see Fig. 3), with both buffers containing 1% Triton X-100 and
protease inhibitors (1). Lysate was centrifuged to remove insoluble
material and diluted into SDS sample buffer. (b)
Alternatively, cells were lysed in 1% SDS and 1 M
H3PO4 and subsequently diluted into sample
buffer for Western blotting or dot blotting. For reasons that are yet unclear, we consistently saw a higher level of background R5 signal on
dot blots (see Figs. 5 and 6) and gels (data not shown) of samples
stopped with H3PO4/SDS stop medium compared
with that seen when cells were harvested in 1% Triton X-100 (see Figs.
3 and 4).
NKCC1 32P Incorporation in Shark Rectal Gland
Tubules--
Shark rectal gland tubule isolation and 32P
incorporation were conducted as previously described (1, 15). At
specific time points following appropriate incubations, 200-µl
aliquots of tubules were pelleted; resuspended in 100 µl of
phosphatase inhibitory buffer containing 3% Triton X-100, 1 µM calyculin A, and a mixture of protease inhibitors;
snap-frozen in liquid nitrogen; and stored at 80 °C. For NKCC1
immunoprecipitation, samples were thawed and centrifuged, and J4
antibody-Sepharose beads (15) were added to the supernatant.
After an overnight incubation at 4 °C with subsequent washing,
samples were subjected to SDS gel electrophoresis with Western blotting
as described above. 32P incorporation into proteins was
analyzed on gels and blots using a PhosphorImager (Molecular Dynamics,
Inc., Sunnyvale, CA).
Tissue Perfusion and Fixation--
Sprague-Dawley rats (Charles
River Laboratories, Wilmington, MA) were anesthetized via
intraperitoneal injection of sodium pentobarbital (50 mg/kg of body
weight). Each animal was kept warm using a heated plate, and body
temperature was monitored with a rectal thermometer. In most
experiments, a polyvinyl catheter was introduced into the appropriate
artery (common carotid for the parotid gland, thoracic for the trachea,
and mesenteric for the colon), and the animals were infused with
prewarmed Krebs-Henseleit bicarbonate solution (140 mM
Na+, 5.4 mM K+, 1.2 mM
Mg2+, 1.2 mM Ca2+, 124 mM Cl , 21 mM
HCO , 2.4 mM
HPO , 0.6 mM
H2PO , pH 7.4; 300 mosmol/liter adjusted with mannitol). Agonists were added to the
perfusate to stimulate cotransporter activity as explained in the
figure legends for each particular tissue. For Western blot analysis of
parotid tissue, the gland was removed and snap-frozen in liquid nitrogen. Frozen, pestle-ground tissue was placed in boiling SDS sample buffer.
For organ fixation, periodate/lysine/paraformaldehyde fixative was
perfused through the same catheter for 5-15 min (16). Tissues were
removed from the animal and further fixed for 2-4 h at 4 °C. To
achieve best fixation results, the trachea was also filled with
fixative at 20 cm of H2O. Shark rectal glands were isolated from the animals, and each gland was perfused through its
unique artery and treated as described for rat tissues.
Immunofluorescence--
Small sections of fixed tissues were
cryoprotected with 50% polyvinylpyrrolidone in 2.3 M
sucrose overnight at 4 °C. Tissue sections were then mounted on
aluminum nails and snap-frozen in liquid nitrogen. Semi-thin
0.5-1-µm sections were cut using a Reichert Ultracut E
ultramicrotome fitted with a FC-4E cryoattachment. Sections were
placed on coated slides (Superfrost Plus, Erie Scientific, Portsmouth,
NH) and washed with PBS prior to antigen retrieval by incubating the
tissues with 1% SDS for 5 min. After quenching with NH4Cl
for 15 min, sections were blocked with 0.1% bovine serum albumin and
10% goat serum in PBS, incubated for 1-2 h with the primary antibody,
washed, and incubated with the appropriate secondary antibody
conjugated to fluorescein isothiocyanate or Alexa dyes (Molecular
Probes, Inc.). Sections were washed three times with PBS and mounted
with Vectashield (Vector Laboratories, Inc., Burlingame, CA), and
micrographs were taken with a Zeiss Axiophot microscope on Kodak Tmax
100 film (Eastman Kodak Co.) or using an Olympus Fluoview confocal microscope.
 |
RESULTS AND DISCUSSION |
In the accompanying paper (1), Darman and Forbush identify three
phosphoacceptor threonines in an activation domain in the N terminus of
shark NKCC1. In particular, phosphorylation of Thr184 and
Thr189 is highlighted as a key element in NKCC1 cotransport
activation. Because this region is well conserved both across species
and between isoforms, it is an excellent candidate as a universal regulatory motif for NKCC. Thus, we prepared a diphosphorylated peptide
corresponding to this region of the human NKCC1 sequence (Tyrh208-Argh223-Lys) and raised a
polyclonal antibody (R5) using the keyhole limpet hemocyanin-conjugated
peptide as antigen.
Analysis of the Phosphorylation State of the Regulatory Threonines
in sNKCC1- and hNKCC1-transfected HEK-293 Cells--
The specificity
of R5 for phosphorylated NKCC is illustrated by the Western blot in
Fig. 2. As shown here, R5 recognized a single protein of ~180 kDa, corresponding to the Na-K-Cl
cotransporter (see Fig. 3). HEK-293 cells transfected with shark or
human NKCC showed a strong signal compared with native NKCC in HEK-293
cells transfected with vector alone. Cross-reactivity of the R5
antibody with other proteins was not detected in HEK-293 cells and is
rarely seen in lysates of eukaryotic cells.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 2.
Detection of NKCC1 phosphorylation using the
R5 antibody. sNKCC1-, vector-, and hNKCC1-transfected HEK-293
cells were incubated for 1 h in low Cl hypotonic
medium (+) or high K+ medium ( ) to activate or deactivate
NKCC1. After solubilization of the cells in Triton X-100 with protease
inhibitors, samples were incubated for an additional 90 min at room
temperature in the presence (+) or absence ( ) of 0.5 µM
calyculin A (cal. A), prior to the addition of SDS sample
buffer, gel electrophoresis, and Western blotting.
|
|
To investigate the activation dependence of the R5 signal, we incubated
NKCC1-transfected HEK-293 cells in low Cl hypotonic
medium (3 mM Cl solution diluted
2-fold with water) or in high K+ medium (135 mM NaCl, 5 mM RbCl, 1 mM
CaCl2/MgCl2, 1 mM
Na2HPO4/Na2SO4, 15 mM
NaHEPES, pH 7.4, and 10 mM K+) to activate or
deactivate the transporter, respectively. As illustrated in Fig. 2, the
antibody signal was severalfold greater in sNKCC1- and
hNKCC1-transfected HEK-293 cells under activating conditions. As a
further confirmation that the R5 signal is dependent upon
phosphorylation of the cotransporter, the samples in this experiment
were incubated at room temperature for 90 min following lysis of the
cells to allow endogenous protein phosphatases to dephosphorylate
NKCC1. As shown here, the R5 signal was almost completely eliminated by
incubation in lysis buffer devoid of the protein phosphatase-1
inhibitor calyculin A.
We examined various NKCC phosphorylation site mutants to determine
whether R5 recognizes the monophosphorylated as well as the
diphosphorylated regulatory domains. Fig.
3 presents Western blots of transfected
HEK-293 cells from such an experiment comparing vector alone, wild-type
sNKCC1, and Thr184/Thr189 mutants under the
activation and deactivation conditions described above. Total
shark NKCC1 was indicated by J3 antibody binding (Fig. 3, middle
panel); as shown here, the expression was similar for each of the
constructs. For both Thr184 and Thr189 single
mutants, the R5 signal was found to increase with activation (Fig. 3,
upper panel), and although the level was clearly greater than in control HEK-293 cells, there was much less signal than for
wild-type sNKCC1. The simplest explanation for this result is that the
R5 antibody, although having the greatest affinity for the
diphosphorylated regulatory domain, also has significant although lower
affinity for the monophosphorylated forms.

View larger version (64K):
[in this window]
[in a new window]
|
Fig. 3.
Recognition of Thr184 and
Thr189 mutants by the R5 antibody. sNKCC1- and
vector-transfected HEK-293 cells were preincubated in low
Cl hypotonic medium (+) or high K+ medium
( ) for 50 min prior to lysis in Triton X-100 with protease and
phosphatase inhibitors. After centrifugation and dilution into SDS
sample buffer, identical volumes of solubilized protein representing 6 mm2 of tissue culture monolayer were loaded. Coomassie Blue
staining of blots showed ~20% variation in protein levels among
these samples; to correct for this variation, individual lanes in all
three panels have been digitally corrected accordingly. The sNKCC1
mutants are described in the accompanying paper (1) (PKA-1 denotes
186GHNT RRNT). Upper panel, R5 Western blot
analysis of sNKCC1 phosphorylation site mutants and wild-type sNKCC1-
and vector-transfected HEK-293 cells; middle panel, a
parallel blot probed with the J4 antibody to detect total sNKCC1
expression; lower panel, Coomassie Blue stain of the blot in
A.
|
|
The J3 antibody consistently recognized two bands in transfected cells
(Fig. 3, middle panel), and we presume that this is due to
different degrees of glycosylation, possibly reflecting different
subcellular compartmentalization. Only the upper of these two bands was
phosphorylated upon activation, as demonstrated by R5 recognition (the
T189D mutant may exhibit a small amount of another lower band). The
identity of the R5-positive band of lesser mobility in deactivated
cells is a puzzle. Our interpretation is that this signal is from the
endogenous HEK-293 cell cotransporter, based on two observations.
(a) There was little or no J3 signal at this position (this
R5 signal was from the region between the two strong J3 bands, better
seen in superimposition of reblotting experiments (data not shown));
and (b) the upper J3 band exhibited only a very small upward
mobility shift upon activation of the transporter. Surprisingly, and
somewhat at odds with this interpretation, the native HEK-293 cell
cotransporter appeared to undergo a mobility shift upon
phosphorylation, despite the fact that the amount of HEK-293 cell R5
signal did not increase much upon activation (Figs. 2 and 3 and
discussion below).
Relationship between the R5 Antibody Signal and 32P
Incorporation in NKCC1--
To analyze the phosphorylation state of
sNKCC1 residues Thr184/Thr189 in their native
cellular environment, we examined 32P incorporation and R5
binding in isolated shark rectal gland tubules preloaded with
32Pi (1). Tubules were activated by incubation
either in hypertonic media or in isotonic media containing forskolin
(to activate apical Cl channels and to lower
intracellular [Cl ] (8)) and calyculin A. Under both
conditions, NKCC1 displayed a time-dependent increase of
32P incorporation in the 195-kDa band of NKCC1 as detected
by 32P phosphorimaging of samples subjected to gel
electrophoresis and transferred to polyvinylidene difluoride membranes
(Fig. 4A); immunoprecipitation
with the J4 antibody highlighted 32P phosphorylation of
NKCC1 (Fig. 4B). Using the R5 antibody, NKCC1 phosphorylation was readily detected even in the crude lysates (Fig.
4C). Fig. 4 (D-F) illustrate the quantitative
relationship between the R5 signal and 32P incorporation.
It is clear from these data that R5 binding varies linearly with
32P incorporation within our measurements, both in crude
lysates (Fig. 4, D and E) and in
immunoprecipitates (Fig. 4F). Thus, Thr184 and
Thr189 are indicators of overall sNKCC1 phosphorylation
under these conditions, providing rational support for the use of R5 as
a quantitative tool.

View larger version (69K):
[in this window]
[in a new window]
|
Fig. 4.
Correlation between R5 antibody signal and
32P incorporation. Shark rectal gland tubules were
preloaded with 32P for 40 min and then incubated in shark
Ringer's solution with forskolin (10 µM) and calyculin A
(0.5 µM) or with the addition of 580 mM
sucrose for the indicated times prior to solubilization in 1% Triton
X-100 with phosphatase and protease inhibitors. A,
phosphorimage of whole cell lysate subjected to SDS gel electrophoresis
and transferred to polyvinylidene difluoride membrane; B,
phosphorimage of NKCC1 immunopurified with the J4 antibody;
C, blot of whole cell lysate from A probed with
the R5 antibody (Western blot); D-F, comparison of NKCC1
32P incorporation and R5 binding by quantitation of
phosphorimages and Western blots. Closed symbols, activation
in hypertonic media; open symbols, forskolin and calyculin A
activation. D shows data from the images in A and
C (analysis of whole cell lysates). E and
F show combined data from three experiments (not including
the one presented in D) in which the samples were analyzed
together. Different symbols indicate different experiments.
E shows the results from the analysis of whole cell
lysates. F shows the results from the analysis of J4
immunoprecipitates.
|
|
To further establish the relationship between phosphorylation and NKCC1
activation, we compared the effects of several activation media on the
R5 signal and 86Rb influx. Fig.
5 illustrates the results of an
experiment, similar to that of Fig. 8 of the accompanying paper (1), in
which the time course of activation and deactivation was determined in
various media. Following preincubation of cells in a single 96-well
plate for each cell line, alternate rows were either lysed in
H3PO4/SDS for dot-blot analysis (possible
because only a single band was detected by R5; Fig. 1) or subjected to
a 1-min 86Rb influx assay. It is readily seen in Fig. 5
that function mirrors phosphorylation, i.e. activating and
deactivating conditions had similar effects on both measurements (a
small discrepancy between phosphorylation and flux for hNKCC1 cells in
low Cl hypotonic medium transferred to
0Na-0K-130Cl hypertonic medium was seen in two of four such
experiments). Human and shark NKCC1 exhibited similar behavior, except
that hNKCC1 was less activated by the hypertonic sucrose medium.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 5.
Time courses of phosphorylation of NKCC1 and
of activation of NKCC-mediated 86Rb influx.
Transfected HEK-293 cells were preincubated for 30 min in basic
medium (135 mM NaCl, 5 mM RbCl, 1 mM CaCl2/MgCl2, 1 mM
Na2HPO4/Na2SO4, and 15 mM NaHEPES, pH 7.4) (open symbols) or low
Cl hypotonic medium (closed symbols). A second
preincubation, for the times plotted on the abscissa, was
carried out in 0Na-0K-130Cl hypertonic medium (red dashed
lines, , O), low Cl hypotonic medium
(black solid lines, ), low Cl
medium (purple dotted lines, ), hypertonic medium
(blue solid lines, ), or basic medium
(green dashed lines, ). In alternate rows of the
plate, a 2-min 86Rb influx was then carried out in regular
flux medium (basic medium with ~1 µCi/ml 86Rb
and 10 4 M ouabain) (upper panels);
or the wells were sucked dry, rapidly solubilized in 70 µl of
H3PO4/SDS, and dot-blotted with the R5 antibody
(lower panels). Each point shows the value of the flux in a
single well or, in the two curves for which error bars are
shown, the mean and range in duplicate wells. Similar
results were obtained in three other experiments.
|
|
We have used similar experiments to answer a question regarding the
mechanism by which the T202E mutation produces a profound change in the
pattern of cotransporter activation, abolishing the stimulation by
hypertonic media (1). Fig. 6 presents the results of an experiment involving four activation conditions, each
evaluated by R5 dot-blot analysis and by 86Rb influx assays
of samples from the same plate. For sNKCC1-transfected cells, the
cotransporter was activated both by low Cl hypotonic
medium and by 0Na-0K hypertonic medium; the results are similar to
those in Fig. 5 in that the changes in 86Rb influx mirrored
the changes in the R5 signal. For the T202E mutant, 86Rb
influx was slightly increased over basal levels in 0Na-0K-130Cl hypertonic medium compared with low Cl hypotonic medium,
and again this pattern was reproduced by the changes in the observed R5
signal. This result demonstrates that the effect of the
Thr202 mutation on cotransporter activation is the result
of a change in the degree to which
Thr184/Thr189 are phosphorylated by various
stimuli.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 6.
86Rb influx and phosphorylation
in the T202E mutant. sNKCC1-, T202E-, and vector-transfected cells
were preincubated for two sequential 30-min preincubation periods as
follows: black bars, basic/basic medium; dark gray
bars, basic/0Na-0K-130Cl hypertonic medium; light gray
bars, low Cl hypotonic/0Na-0K-130Cl hypertonic
medium; white bars, basic/low Cl hypotonic
medium. Following preincubation, 86Rb influx was performed
on one-fourth of the plate (upper panel, n = 6 on one plate); and the other wells were sucked dry, and
H3PO4/SDS was added for dot blotting with the
R5 antibody (lower panel, n = 18 on the same
plate). A constant background value was subtracted from all dot-blot
values; this represented 22, 50, and 54% of the maximum R5 dot signal
in sNKCC1, T202E, and the vector, respectively. Data are plotted as
means ± S.E. relative to the value with the last of the four
preincubation protocols.
|
|
Fig. 6 also illustrates an anomalous result with regard to the R5
signal of the endogenous HEK-293 cell cotransporter. Following preincubation in the normal flux medium, the R5 signal was high, although the flux was only ~20% activated (we suspect that a
tendency of T202E in the same direction may be due to contamination by the endogenous HEK-293 cell signal). It is important to note that there
was a relatively high level of R5 signal in HEK-293 cells (see the
legend to Fig. 6 and "Experimental Procedures") and that there
was only a small fractional change on top of this. This phenomenon is
also seen in the Western blots of Figs. 2 and 3, where the change in
the HEK-293 cell R5 signal was very small upon activation. The nature
of the HEK-293 cell cotransporter remains an enigma: although reverse
transcription-PCR results are more consistent with its identity as
NKCC1, its regulatory behavior is distinctly different from that of
overexpressed human NKCC1 in several regards (1, 17).
Activation of NKCC1 in Intact Shark Rectal Gland--
Previously,
in vivo analysis of NKCC1 activation in native tissue has
been difficult. Earlier studies by ourselves and others have used
measurements of [3H]benzmetanide binding, 32P
incorporation, or 86Rb uptake to measure NKCC1 activation
in vitro, but it is usually impractical to apply these
techniques in an intact tissue or animal model. To carry out these
analyses, the tissue must be extracted and digested to isolate
epithelial cells, possibly altering the NKCC1 activation state prior to
analysis. To date, there have been no studies analyzing the
phosphorylation state of NKCC1 in native tissue. We investigated
whether the R5 antibody can be used for measuring sNKCC1 activity
in situ, utilizing tissue fixation to arrest enzymatic
reactions that could alter phosphorylation states. In Fig.
7, immunohistographs of shark rectal
gland perfused with shark Ringer's solution (240 mM NaCl, 4 mM KCl, 2.5 mM
CaCl2, 1.25 mM MgSO4, 20 mM HEPES, 70 mM trimethylamine
N-oxide, 350 mM urea, 1.0 mM
Na2HPO4, and 5.6 mM
D-glucose, adjusted to pH 7.8 at room temperature and
bubbled with O2) in the presence or absence of forskolin
show a dramatic increase in R5 staining along the basolateral membrane
of the secretagogue-perfused tubular epithelium. Probing with the J4
antibody verified the subcellular localization of NKCC1 to this region
under stimulatory and basal conditions. The strong correlation confirms
the specificity of R5 as sufficient for in situ analysis and
reveals the importance of the two conserved threonines in the
regulation of sNKCC1 in its native tissue. In addition, although the R5
antibody was raised against the human sequence, its affinity and
specificity in elasmobranches as well as teleosts (18) are consistent
with conservation of the regulatory motif across evolutionarily distant
species.

View larger version (55K):
[in this window]
[in a new window]
|
Fig. 7.
sNKCC1 activation in
vivo. Shown are immunohistographs of semi-thin sections
from shark rectal glands perfused with shark Ringer's solution
in the absence (left panels) or presence (middle
panels) of forskolin (Forsk; 50 µM) and
probed simultaneously with J4 and R5 antibodies. The superimposition of
the two signals is also shown (right panels), demonstrating
colocalization of the two antigens.
|
|
NKCC1 in the Parotid Gland--
Numerous reports of divergent
stimuli causing activation of NKCC1 in the parotid gland support a
complex pattern of regulation in this tissue (3). In this study, we
perfused the parotid gland in vivo in the absence or
presence of the -adrenergic receptor agonist isoproterenol; the
subsequent rise in intracellular cAMP has been previously shown to
increase NKCC1 activity in this tissue (19, 20). In Fig.
8 (a and b), tissue
homogenate subjected to gel electrophoresis and probed with the R5
antibody displayed a 170-kDa band whose identity as NKCC1 was confirmed
by the T4 antibody. Densitometric band analysis revealed a 2-fold
increase in the R5/T4 ratio under stimulatory conditions (Fig.
8c). In addition to the 170-kDa protein, the C-terminal T4
antibody detected a second band with an apparent molecular mass of 140 kDa. This band was not strongly recognized by the R5 antibody, and
we presume it to represent immature, non-phosphorylated NKCC1
retained in intracellular compartments.

View larger version (59K):
[in this window]
[in a new window]
|
Fig. 8.
R5 analysis in rat parotid gland.
a, Western blot analysis of rat parotid gland perfused with
Krebs-Henseleit solution in the presence (+) or absence ( ) of
isoproterenol (Iso; 5 µM). The membrane was
probed with the T4 antibody (right panel), stripped,
and probed with the R5 antibody (left panel). The 170-kDa
band (but not the 140-kDa band) corresponds to the R5 band
((+)-isoproterenol versus ( )-isoproterenol
(n = 4); p < 0.05). b,
densitometric band analysis of the data in a. c,
expression of results in b. Values represent the ratio of
phosphorylated NKCC1 to total NKCC1 given by R5 signal/T4 signal. Data
are represented as means ± S.D. and were tested by paired
Student's t test for significance at the 5% level.
d, immunohistographs of semi-thin sections of rat parotid
gland perfused with shark Ringer's solution in the absence
(left and right panels) or presence (middle
panel) of isoproterenol (5 µM). Tissues were probed
with the R5 (left and middle panels) and N1c
(right panel) antibodies, respectively. Ctrl,
control.
|
|
In situ analysis of rat parotid gland with the R5 antibody
revealed pronounced staining along the basolateral membrane in ductal
and acinar cells of glands perfused with isoproterenol (Fig.
8d). Basolateral staining with the N1c antibody confirmed that NKCC1 was expressed in both cell types. The finding that NKCC1 is
abundantly expressed in the duct epithelium of rat parotid gland
contrasts markedly with our previous finding of rabbit parotid gland
NKCC1 expression only in the acini (12). This expression profile was
confirmed (data not shown) and thus suggests a striking species-specific difference in the function of the duct epithelium.
NKCC1 in the Trachea--
In the trachea, as in many other
secretory tissues, NKCC1 works in concert with the cystic fibrosis
transmembrane conductance regulator to aid in the vectorial secretion
of fluid into the lumen (2). Haas et al. (7) have previously
described NKCC1 activation in isolated dog epithelial cell preparations
in response to -adrenergic receptor agonists. This activation
appears, like that in the rectal gland, to occur primarily via a
transient reduction in intracellular [Cl ] resulting
from the apical exit of chloride.
Fig. 9a demonstrates that
NKCC1 expression is localized to the basolateral membrane of the
epithelial cell layer of rat trachea. Interestingly, we also found
heavy, non-polarized staining of the basal cells directly beneath this
epithelial cell monolayer, as well as heavy N1c staining of the
subepithelial gland (Fig. 9b, arrow). Fig. 9
(c and d) illustrates that the R5 antibody selectively stained along the basolateral membrane of the epithelial layer and the cell membrane of non-polarized basal cells in rats perfused with isoproterenol. This result demonstrates the activation of
NKCC1 in the intact trachea in response to -adrenergic receptor agonists, supporting the previous analysis with isolated cells. The
high level of NKCC1 expression and activity in basal cells were
unexpected. However, because these basal cells demarcate a
proliferation zone (21) and NKCC1 activity has been linked to cell
cycle regulation (reviewed in Ref. 22) and cell proliferation (23), we
speculate that active NKCC1 could play an important role in mediating
cell growth in this tissue.

View larger version (95K):
[in this window]
[in a new window]
|
Fig. 9.
NKCC1 activation in rat trachea. Shown
are immunohistographs of semi-thin sections of rat trachea perfused
with Krebs-Henseleit solution in the absence (a-c) or
presence (d) of isoproterenol (Iso; 5 µM). Tissues were probed with the R5 (c and
d) and N1c (a and b) antibodies,
respectively. NKCC1 is seen in the epithelial cells, including the
germinal layer, and in subepithelial glands (arrow in
b). Ctrl, control.
|
|
NKCC1 in the Distal Colon--
In this secretory tissue,
NKCC1 activity has been linked to both K+ and
Cl secretion (24, 25). This NKCC1-mediated secretory
activity has been linked to both - and 2-adrenergic
receptors, respectively, through increases in intracellular [cAMP],
with a resultant fall in intracellular chloride, and through increases
in intracellular [Ca2+], with the activation of
basolateral K+ recycling channels (26).
In Fig. 10, the R5 antibody was used to
address the activation state of NKCC1 in response to - and
-adrenergic receptor agonists (epinephrine and isoproterenol,
respectively). In tissue perfused with isoproterenol, strong staining
was observed in the base of the crypts and decreased markedly along the
crypt-villus axis. NKCC1 was expressed throughout the crypt, as
demonstrated by T4 antibody binding and similar to the expression
profile of the gastric gland. This segregation of activity further
supports the hypothesis that the base of the crypts constitutes a
region of cell proliferation and secretion (27, 28).

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 10.
NKCC1 activation in rat colon.
Semi-thin sections of rat colon perfused with Krebs-Henseleit solution
containing either epinephrine (Epi; 10 µM) or
isoproterenol (Iso; 5 µM) were immunostained
with the R5 (left panels) and T4 (right
panel) antibodies.
|
|
R5 staining was negative in epinephrine-perfused tissue (Fig. 10) and
was similar to levels observed in control animals (data not shown). We
believe that the absence of NKCC1 stimulation by epinephrine may be due
to stimulation of G i via 1-adrenergic receptors in this colonic segment. This would correlate the response of
NKCC1 to adrenergic stimuli with the local expression of receptor subtypes.
Limitations on the Use of the R5 Antibody--
Although the R5
antibody has proven to be an outstanding tool for the investigation of
cotransporter regulation, we have identified a number of limitations in
its utilization. (a) It must be noted that, although R5
recognizes two phosphoacceptor sites in NKCC, available data imply that
at least five phosphoacceptors are utilized in regulatory
phosphorylation (see "Discussion" in the accompanying paper (1)).
Also, although most experiments have supported the concept of
phosphorylation by a single kinase, recent studies have raised the
possibility of alternate modes of regulation (1, 3). (b) In
the work presented here, we examined regulation of NKCC1 in secretory
tissues in which it is very highly expressed. We have found that R5 is
not suitable for immunofluorescence studies in tissues with lower
levels of cotransporter expression due to background staining of
cytoplasm and particularly of nuclei. (c) We are puzzled by
a high level of R5 background signal when phosphorylation and
dephosphorylation are "stopped" by acid and SDS compared with when
they are stopped by Triton X-100, EDTA, and phosphatase
inhibitors (see "Experimental Procedures"). (d) Although
the R5 signal mirrors transport function both in shark rectal gland
cells and in HEK-293 cells overexpressing shark or human NKCC1, in
wild-type HEK-293 cells, there is an anomalously high R5 signal under
basal conditions (Figs. 2, 3, and 6). We currently have no explanation
for this observation, but appreciate that it may complicate the
interpretation of future experiments in similar cell types.
Conclusions--
As demonstrated above, the R5 antibody enables us
to directly investigate the phosphorylation state of the two conserved
threonines in cells and tissues and to discern the subcellular
localization of activated NKCC1 via immunofluorescence. We show the
first reported data of NKCC1 activation in vivo using fixed
sections of secretory tissue. Analyzing these data, we conclude that
Thr(P)184 and/or Thr(P)189 in shark and the
homologous mammalian residues parallel NKCC1 activation in
vivo and that this phosphorylation profile is independent of the
tissue type and vertebrate species tested. We propose that these
regulatory threonines are part of a universal regulatory locus
necessary for NKCC1 activation.
 |
ACKNOWLEDGEMENTS |
We thank James Elliot (W. M. Keck
Facility, Yale University) for phosphopeptide synthesis, Chris Lytle
for the N1c antibody, Sue Ann Mentone for expert preparation of
histological samples, and Grace Dillard for excellent technical assistance.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant DK47661.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: University Children's Hospital Munich,
Lindwurmstrasse 4, 80337 Munich, Germany.
§
Present address: Dept. of Molecular Medicine, Beth Israel
Deaconess Medical Center, Harvard Medical School, Boston, MA 02215.
¶
To whom correspondence and reprint requests should be
addressed: Dept. of Cellular and Molecular Physiology, Yale University School of Medicine, 333 Cedar St., New Haven, CT 06520-0826. Tel.: 203-785-4068; Fax: 203-785-6834; E-mail:
biff.forbush@yale.edu.
Published, JBC Papers in Press, July 26, 2002, DOI 10.1074/jbc.M206294200
 |
ABBREVIATIONS |
The abbreviations used are:
sNKCC1, shark
NKCC1;
hNKCC1, human NKCC1;
ELISA, enzyme-linked immunosorbent assay;
PBS, phosphate-buffered saline;
Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine.
 |
REFERENCES |
| 1.
|
Darman, R. B.,
and Forbush, B.
(2002)
J. Biol. Chem.
277,
37542-37550[Abstract/Free Full Text]
|
| 2.
|
Haas, M.,
and Forbush, B., III
(2000)
Annu. Rev. Physiol.
62,
515-534[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Tanimura, A.,
Kurihara, K.,
Reshkin, S. J.,
and Turner, R. J.
(1995)
J. Biol. Chem.
270,
25252-25258[Abstract/Free Full Text]
|
| 4.
|
Evans, R. L.,
and Turner, R. J.
(1997)
J. Physiol. (Lond.)
499,
351-359[Abstract/Free Full Text]
|
| 5.
|
Forbush, B., III,
Haas, M.,
and Lytle, C.
(1992)
Am. J. Physiol.
262,
C1000-C1008[Abstract/Free Full Text]
|
| 6.
|
Payne, J. A., Xu, J. C.,
Haas, M.,
Lytle, C. Y.,
Ward, D.,
and Forbush, B., III
(1995)
J. Biol. Chem.
270,
17977-17985[Abstract/Free Full Text]
|
| 7.
|
Haas, M.,
Johnson, L. G.,
and Boucher, R. C.
(1990)
Am. J. Physiol.
259,
C557-C569[Abstract/Free Full Text]
|
| 8.
|
Lytle, C.,
and Forbush, B., III
(1996)
Am. J. Physiol.
270,
C437-C448[Abstract/Free Full Text]
|
| 9.
|
Lytle, C.,
and Forbush, B., III
(1992)
J. Biol. Chem.
267,
25438-25443[Abstract/Free Full Text]
|
| 10.
|
Kurihara, K.,
Moore-Hoon, M. L.,
Saitoh, M.,
and Turner, R. J.
(1999)
Am. J. Physiol.
277,
C1184-C1193[Abstract/Free Full Text]
|
| 11.
|
Darman, R. B.,
Flemmer, A.,
and Forbush, B.
(2001)
J. Biol. Chem.
276,
34359-34362[Abstract/Free Full Text]
|
| 12.
|
Lytle, C., Xu, J. C.,
Biemesderfer, D.,
and Forbush, B., III
(1995)
Am. J. Physiol.
269,
C1496-C1505[Abstract/Free Full Text]
|
| 13.
|
McDaniel, N.,
and Lytle, C.
(1999)
Am. J. Physiol.
276,
G1273-G1278[Abstract/Free Full Text]
|
| 14.
|
Lytle, C., Xu, J. C.,
Biemesderfer, D.,
Haas, M.,
and Forbush, B., III
(1992)
J. Biol. Chem.
267,
25428-25437[Abstract/Free Full Text]
|
| 15.
|
Lytle, C.,
and Forbush, B., III
(1992)
Am. J. Physiol.
262,
C1009-C1017[Abstract/Free Full Text]
|
| 16.
|
McClean, W.,
and Nakane, P. F.
(1973)
J. Histochem. Cytochem.
22,
1077-1083[Abstract]
|
| 17.
|
Isenring, P.,
Jacoby, S. C.,
Payne, J. A.,
and Forbush, B., III
(1998)
J. Biol. Chem.
273,
11295-11301[Abstract/Free Full Text]
|
| 18.
|
Flemmer, A. W.,
and Forbush, B., III
(1999)
FASEB J.
13,
A399
|
| 19.
|
Paulais, M.,
and Turner, R. J.
(1992)
J. Clin. Invest.
89,
1142-1147[Medline]
[Order article via Infotrieve]
|
| 20.
|
Kurihara, K.,
Nakanishi, N.,
Moore-Hoon, M. L.,
and Turner, R. J.
(2002)
Am. J. Physiol.
282,
C817-C823[Abstract/Free Full Text]
|
| 21.
|
Boers, J. E.,
Ambergen, A. W.,
and Thunnissen, F. B.
(1998)
Am. J. Respir. Crit. Care Med.
157,
2000-2006[Abstract/Free Full Text]
|
| 22.
|
Russell, J. M.
(2000)
Physiol. Rev.
80,
211-276[Abstract/Free Full Text]
|
| 23.
|
Panet, R.,
Marcus, M.,
and Atlan, H.
(2000)
J. Cell. Physiol.
182,
109-118[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Halm, D. R.,
and Frizzell, R. A.
(1986)
Am. J. Physiol.
251,
C252-C267[Abstract/Free Full Text]
|
| 25.
|
Dharmsathaphorn, K.,
Mandel, K. G.,
Masui, H.,
and McRoberts, J. A.
(1985)
J. Clin. Invest.
75,
462-471[Medline]
[Order article via Infotrieve]
|
| 26.
|
Schultheiss, G.,
and Diener, M.
(2000)
Eur. J. Pharmacol.
403,
251-258[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
D'Andrea, L.,
Lytle, C.,
Matthews, J. B.,
Hofman, P.,
Forbush, B., III,
and Madara, J. L.
(1996)
J. Biol. Chem.
271,
28969-28976[Abstract/Free Full Text]
|
| 28.
|
Matthews, J. B.,
Hassan, I.,
Meng, S.,
Archer, S. Y.,
Hrnjez, B. J.,
and Hodin, R. A.
(1998)
J. Clin. Invest.
101,
2072-2079[Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. E. Yang, M. B. Sandberg, A. D. Can, K. Pihakaski-Maunsbach, and A. A. McDonough
Effects of dietary salt on renal Na+ transporter subcellular distribution, abundance, and phosphorylation status
Am J Physiol Renal Physiol,
October 1, 2008;
295(4):
F1003 - F1016.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Smith, N. Smallwood, A. Altman, and C. M. Liedtke
PKC{delta} Acts Upstream of SPAK in the Activation of NKCC1 by Hyperosmotic Stress in Human Airway Epithelial Cells
J. Biol. Chem.,
August 8, 2008;
283(32):
22147 - 22156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ponce-Coria, P. San-Cristobal, K. T. Kahle, N. Vazquez, D. Pacheco-Alvarez, P. de los Heros, P. Juarez, E. Munoz, G. Michel, N. A. Bobadilla, et al.
Regulation of NKCC2 by a chloride-sensing mechanism involving the WNK3 and SPAK kinases
PNAS,
June 17, 2008;
105(24):
8458 - 8463.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Pedersen, M. Carmosino, and B. Forbush
Intramolecular and Intermolecular Fluorescence Resonance Energy Transfer in Fluorescent Protein-tagged Na-K-Cl Cotransporter (NKCC1): SENSITIVITY TO REGULATORY CONFORMATIONAL CHANGE AND CELL VOLUME
J. Biol. Chem.,
February 1, 2008;
283(5):
2663 - 2674.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Reynolds, A. Parris, L. A. Evans, S. Lindqvist, P. Sharp, M. Lewis, R. Tighe, and M. R. Williams
Dynamic and differential regulation of NKCC1 by calcium and cAMP in the native human colonic epithelium
J. Physiol.,
July 15, 2007;
582(2):
507 - 524.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Kaunitz
NKCC1: tales from the dark side of the crypt
J. Physiol.,
July 15, 2007;
582(2):
477 - 477.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Pieraut, V. Laurent-Matha, C. Sar, T. Hubert, I. Mechaly, C. Hilaire, M. Mersel, E. Delpire, J. Valmier, and F. Scamps
NKCC1 Phosphorylation Stimulates Neurite Growth of Injured Adult Sensory Neurons
J. Neurosci.,
June 20, 2007;
27(25):
6751 - 6759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. R. Gawenis, E. M. Bradford, V. Prasad, J. N. Lorenz, J. E. Simpson, L. L. Clarke, A. L. Woo, C. Grisham, L. P. Sanford, T. Doetschman, et al.
Colonic Anion Secretory Defects and Metabolic Acidosis in Mice Lacking the NBC1 Formula Cotransporter
J. Biol. Chem.,
March 23, 2007;
282(12):
9042 - 9052.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. B. Kintner, J. Luo, J. Gerdts, A. J. Ballard, G. E. Shull, and D. Sun
Role of Na+-K+-Cl- cotransport and Na+/Ca2+ exchange in mitochondrial dysfunction in astrocytes following in vitro ischemia
Am J Physiol Cell Physiol,
March 1, 2007;
292(3):
C1113 - C1122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Dimke, A. Flyvbjerg, S. Bourgeois, K. Thomsen, J. Frokiaer, P. Houillier, S. Nielsen, and S. Frische
Acute growth hormone administration induces antidiuretic and antinatriuretic effects and increases phosphorylation of NKCC2
Am J Physiol Renal Physiol,
February 1, 2007;
292(2):
F723 - F735.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. T. Kahle, J. Rinehart, A. Ring, I. Gimenez, G. Gamba, S. C. Hebert, and R. P. Lifton
WNK Protein Kinases Modulate Cellular Cl- Flux by Altering the Phosphorylation State of the Na-K-Cl and K-Cl Cotransporters.
Physiology,
October 1, 2006;
21:
326 - 335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Pacheco-Alvarez, P. S. Cristobal, P. Meade, E. Moreno, N. Vazquez, E. Munoz, A. Diaz, M. E. Juarez, I. Gimenez, and G. Gamba
The Na+:Cl- Cotransporter Is Activated and Phosphorylated at the Amino-terminal Domain upon Intracellular Chloride Depletion
J. Biol. Chem.,
September 29, 2006;
281(39):
28755 - 28763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. Anselmo, S. Earnest, W. Chen, Y.-C. Juang, S. C. Kim, Y. Zhao, and M. H. Cobb
WNK1 and OSR1 regulate the Na+, K+, 2Cl- cotransporter in HeLa cells
PNAS,
July 18, 2006;
103(29):
10883 - 10888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-S. N. Chee, J. Kistler, and P. J. Donaldson
Roles for KCC Transporters in the Maintenance of Lens Transparency
Invest. Ophthalmol. Vis. Sci.,
February 1, 2006;
47(2):
673 - 682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. B. Pond, K. Berglund, T. Kuner, G. Feng, G. J. Augustine, and R. D. Schwartz-Bloom
The Chloride Transporter Na+-K+-Cl- Cotransporter Isoform-1 Contributes to Intracellular Chloride Increases after In Vitro Ischemia
J. Neurosci.,
February 1, 2006;
26(5):
1396 - 1406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mercado, V. Broumand, K. Zandi-Nejad, A. H. Enck, and D. B. Mount
A C-terminal Domain in KCC2 Confers Constitutive K+-Cl- Cotransport
J. Biol. Chem.,
January 13, 2006;
281(2):
1016 - 1026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Foroutan, J. Brillault, B. Forbush, and M. E. O'Donnell
Moderate-to-severe ischemic conditions increase activity and phosphorylation of the cerebral microvascular endothelial cell Na+-K+-Cl- cotransporter
Am J Physiol Cell Physiol,
December 1, 2005;
289(6):
C1492 - C1501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Gimenez and B. Forbush
Regulatory phosphorylation sites in the NH2 terminus of the renal Na-K-Cl cotransporter (NKCC2)
Am J Physiol Renal Physiol,
December 1, 2005;
289(6):
F1341 - F1345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Rinehart, K. T. Kahle, P. de los Heros, N. Vazquez, P. Meade, F. H. Wilson, S. C. Hebert, I. Gimenez, G. Gamba, and R. P. Lifton
WNK3 kinase is a positive regulator of NKCC2 and NCC, renal cation-Cl- cotransporters required for normal blood pressure homeostasis
PNAS,
November 15, 2005;
102(46):
16777 - 16782.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. T. Kahle, J. Rinehart, P. de los Heros, A. Louvi, P. Meade, N. Vazquez, S. C. Hebert, G. Gamba, I. Gimenez, and R. P. Lifton
WNK3 modulates transport of Cl- in and out of cells: Implications for control of cell volume and neuronal excitability
PNAS,
November 15, 2005;
102(46):
16783 - 16788.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Brunet, E. Gagnon, C. F. Simard, N. D. Daigle, L. Caron, M. Noel, M.-H. Lefoll, M. J. Bergeron, and P. Isenring
Novel Insights Regarding the Operational Characteristics and Teleological Purpose of the Renal Na+-K+-Cl2 Cotransporter (NKCC2s) Splice Variants
J. Gen. Physiol.,
September 26, 2005;
126(4):
325 - 337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Gagnon, M. J. Bergeron, N. D. Daigle, M.-H. Lefoll, and P. Isenring
Molecular Mechanisms of Cation Transport by the Renal Na+-K+-Cl- Cotransporter: STRUCTURAL INSIGHT INTO THE OPERATING CHARACTERISTICS OF THE ION TRANSPORT SITES
J. Biol. Chem.,
September 16, 2005;
280(37):
32555 - 32563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Gamba
Molecular Physiology and Pathophysiology of Electroneutral Cation-Chloride Cotransporters
Physiol Rev,
April 1, 2005;
85(2):
423 - 493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. S. Marshall, C. G. Ossum, and E. K. Hoffmann
Hypotonic shock mediation by p38 MAPK, JNK, PKC, FAK, OSR1 and SPAK in osmosensing chloride secreting cells of killifish opercular epithelium
J. Exp. Biol.,
March 15, 2005;
208(6):
1063 - 1077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. W Flatman
Activation of ferret erythrocyte Na+-K+-2Cl- cotransport by deoxygenation
J. Physiol.,
March 1, 2005;
563(2):
421 - 431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. F. Simard, N. D. Daigle, M. J. Bergeron, G. M. Brunet, L. Caron, M. Noel, V. Montminy, and P. Isenring
Characterization of a Novel Interaction between the Secretory Na+-K+-Cl- Cotransporter and the Chaperone hsp90
J. Biol. Chem.,
November 12, 2004;
279(46):
48449 - 48456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Lenart, D. B. Kintner, G. E. Shull, and D. Sun
Na-K-Cl Cotransporter-Mediated Intracellular Na+ Accumulation Affects Ca2+ Signaling in Astrocytes in an In Vitro Ischemic Model
J. Neurosci.,
October 27, 2004;
24(43):
9585 - 9597.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhao, R. Hyde, and H. S Hundal
Signalling mechanisms underlying the rapid and additive stimulation of NKCC activity by insulin and hypertonicity in rat L6 skeletal muscle cells
J. Physiol.,
October 1, 2004;
560(1):
123 - 136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. F. Simard, G. M. Brunet, N. D. Daigle, V. Montminy, L. Caron, and P. Isenring
Self-interacting Domains in the C Terminus of a Cation-Cl- Cotransporter Described for the First Time
J. Biol. Chem.,
September 24, 2004;
279(39):
40769 - 40777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sugita, C. Hirono, and Y. Shiba
Gramicidin-perforated Patch Recording Revealed the Oscillatory Nature of Secretory Cl- Movements in Salivary Acinar Cells
J. Gen. Physiol.,
June 28, 2004;
124(1):
59 - 69.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. F. X. Dowd and B. Forbush
PASK (Proline-Alanine-rich STE20-related Kinase), a Regulatory Kinase of the Na-K-Cl Cotransporter (NKCC1)
J. Biol. Chem.,
July 18, 2003;
278(30):
27347 - 27353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Gimenez and B. Forbush
Short-term Stimulation of the Renal Na-K-Cl Cotransporter (NKCC2) by Vasopressin Involves Phosphorylation and Membrane Translocation of the Protein
J. Biol. Chem.,
July 11, 2003;
278(29):
26946 - 26951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Schomberg, J. Bauer, D. B. Kintner, G. Su, A. Flemmer, B. Forbush, and D. Sun
Cross Talk Between the GABAA Receptor and the Na-K-Cl Cotransporter Is Mediated by Intracellular Cl-
J Neurophysiol,
January 1, 2003;
89(1):
159 - 167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. B. Darman and B. Forbush
A Regulatory Locus of Phosphorylation in the N Terminus of the Na-K-Cl Cotransporter, NKCC1
J. Biol. Chem.,
September 27, 2002;
277(40):
37542 - 37550.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|